Pharmaceutical Technology Europe
August 01, 2013
Industry Insider
25
8
Orphan drugs for rare diseases are a major area of investment for pharmaceutical companies, but are they becoming too expensive for Europe to afford them?
August 01, 2013
Issue PDF
25
8
Click the title above to open the Pharmaceutical Technology Europe August 2013 issue in an interactive PDF format.